1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
(
- Contribution to journal › Article
- 2016
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
(
- Contribution to journal › Article
- 2013
-
Mark
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
(
- Contribution to journal › Article
- 2010
-
Mark
Two-Year Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial.
(
- Contribution to journal › Article
-
Mark
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study
(
- Contribution to journal › Article
- 2009
-
Mark
Low toxicity regimens in renal transplantation: a country subset analysis of the Symphony study
(
- Contribution to journal › Article
- 2007
-
Mark
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
(
- Contribution to journal › Article
- 2005
-
Mark
Minimization of immunosuppressive therapy after renal transplantation: Results of a randomized controlled trial
(
- Contribution to journal › Article
- 1999
-
Mark
Inhibition of acute allogaft rejection - experimental transplant studies with biological and chemical immunosuppressants
1999)(
- Thesis › Doctoral thesis (compilation)